Pharmaron Beijing Co., Ltd. (SHE: 300759)

Pharmaron Beijing Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	11,498	11,533	10,240	7,419	5,114	3,737
Other Revenue	4.65	4.61	26.19	24.48	19.55	19.81
Revenue	11,502	11,538	10,266	7,444	5,134	3,757
Revenue Growth (YoY)	2.05%	12.39%	37.92%	45.00%	36.64%	29.20%
Cost of Revenue	7,561	7,422	6,502	4,768	3,215	2,424
Gross Profit	3,942	4,116	3,764	2,676	1,919	1,333
Selling, General & Admin	1,847	1,859	1,728	1,022	745.89	568.58
Research & Development	473.9	448.28	282.32	151.77	105.35	62.87
Other Operating Expenses	129.32	82.75	66.52	44.04	32.9	31.24
Operating Expenses	2,498	2,426	2,098	1,229	898.95	668.19
Operating Income	1,444	1,690	1,667	1,448	1,020	665.16
Interest Expense	-231.42	-182.19	-167.31	-83.07	-23.85	-82.48
Interest & Investment Income	707.12	78.95	109.74	371.99	231.55	9.61
Currency Exchange Gain (Loss)	161.49	147	-42.39	-3.16	-131.23	1.88
Other Non Operating Income (Expenses)	-4.08	-3.61	-2.54	-1.39	-1.35	-1.23
EBT Excluding Unusual Items	2,077	1,730	1,564	1,732	1,095	592.96
Gain (Loss) on Sale of Investments	-22.12	18.75	68.09	119.59	190.86	6.73
Gain (Loss) on Sale of Assets	-27.12	-9.15	-15.3	-4.25	-7.28	-0.67
Other Unusual Items	128.73	98.48	49.5	63.73	40.72	33.53
Pretax Income	2,156	1,838	1,666	1,911	1,319	632.55
Income Tax Expense	275.55	256.11	314.25	290.92	172.38	101.88
Earnings From Continuing Operations	1,881	1,582	1,352	1,620	1,147	530.67
Minority Interest in Earnings	47.75	19.32	22.47	40.95	25.39	16.52
Net Income	1,928	1,601	1,375	1,661	1,172	547.19
Net Income to Common	1,928	1,601	1,375	1,661	1,172	547.19
Net Income Growth	22.42%	16.48%	-17.24%	41.68%	114.25%	64.30%
Shares Outstanding (Basic)	1,774	1,772	1,774	1,781	1,779	1,486
Shares Outstanding (Diluted)	1,777	1,775	1,776	1,820	1,785	1,487
Shares Change (YoY)	0.20%	-0.05%	-2.40%	1.97%	20.06%	11.85%
EPS (Basic)	1.09	0.90	0.78	0.93	0.66	0.37
EPS (Diluted)	1.09	0.90	0.77	0.91	0.66	0.37
EPS Growth	22.17%	16.54%	-15.21%	38.94%	78.46%	46.89%
Free Cash Flow	258.34	-111.78	-807.04	-34.78	332.77	183.98
Free Cash Flow Per Share	0.15	-0.06	-0.45	-0.02	0.19	0.12
Dividend Per Share	0.200	0.200	0.200	0.200	0.133	0.067
Dividend Growth	0%	0%	0%	50.04%	99.85%	36.40%
Gross Margin	34.27%	35.67%	36.67%	35.95%	37.38%	35.49%
Operating Margin	12.55%	14.64%	16.23%	19.45%	19.87%	17.70%
Profit Margin	16.77%	13.88%	13.39%	22.31%	22.84%	14.56%
Free Cash Flow Margin	2.25%	-0.97%	-7.86%	-0.47%	6.48%	4.90%
EBITDA	2,231	2,420	2,227	1,852	1,325	928.02
EBITDA Margin	19.39%	20.97%	21.70%	24.88%	25.81%	24.70%
D&A For EBITDA	787.29	730.42	560.76	404.64	304.85	262.86
EBIT	1,444	1,690	1,667	1,448	1,020	665.16
EBIT Margin	12.55%	14.64%	16.23%	19.45%	19.87%	17.70%
Effective Tax Rate	12.78%	13.93%	18.86%	15.22%	13.07%	16.11%
Revenue as Reported	11,502	11,538	10,266	7,444	5,134	3,757

Source: S&P Capital IQ. Standard template. Financial Sources.